Volume 27, Number 9—September 2021
Research
Severe Acute Respiratory Syndrome Coronavirus 2 in Farmed Mink (Neovison vison), Poland
Table 2
Sample name | Mean coverage of SARS-CoV-2 genome (ONT plus Illumina) | Total Illumina reads† | Total Illumina SARS-CoV-2 reads† | Total Illumina mink reads† |
---|---|---|---|---|
mink_4 | 949.6 | 152,609 | 37 | 131,204 |
mink_5 | 2,776 | 396,259 | 159,484 | 184,135 |
mink_42 | 847.8 | 66,515 | 868 | 34,968 |
mink_46 | 1,039.5 | 387,682 | 25,975 | 241,788 |
mink_48 | 1,151 | 125,328 | 9,526 | 64,363 |
mink_49 | 394.6 | 487,771 | 1,711 | 348,017 |
mink_50 | 1,839.6 | 425,333 | 79,589 | 246,546 |
mink_67 | 882.1 | 167,963 | 10,834 | 114,163 |
mink_76 | 723.0 | 99,660 | 2,105 | 77,945 |
mink_77 | 16,078.5 | 2,424,311 | 1,609,172 | 662,381 |
mink_83 | 111,978.9 | 13,495,934 | 12,730,431 | 611,926 |
mink_88 | 1,205.2 | 1,071,003 | 2,822 | 611,787 |
*ONT, Oxford Nanopore Technology (https://nanoporetech.com); SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. †These columns indicate how many Illumina (https://www.illumina.com) reads were generated for each sample and how many of them were classified as SARS-CoV-2 or American mink genomes.
Page created: June 16, 2021
Page updated: December 08, 2021
Page reviewed: December 08, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.